Shares of the company are trading at $10.92 which is a tad above $10.31, the stock’s 50 day moving average and which is marginally higher than the 200 day moving average of $10.31. The 50 day moving average was up by +5.93% and the 200 day average was up $0.61. Trading volume for ProShares UltraPro Short NASDAQ was 0 on Wednesday. Volume was down nan% under the stocks average daily volume. Investors are more bullish on shares of the company lately if you take note of the downtick in short interest. The company recorded a fall in short interest of -28.08% between September 15, 2017 and September 29, 2017. Short shares fell 8,174 over that period.
The following firms have recently changed their position in ZBIO. As of the end of the quarter Morgan Stanley had bought a total of 893 shares growing its holdings by 482.7%. The value of the investment in ProShares UltraPro Short NASDAQ increased from $3,000 to $14,000 a change of $11,000 since the last quarter. As of quarter end Virtu Financial LLC had acquired 51,449 shares growing its position 478.7%. The value of the investment in ZBIO went from $180,000 to $835,000 a change of 363.9% quarter over quarter.
As of the end of the quarter Ubs Group Ag had disposed of a total of 774 shares trimming its stake by 76.3%. The value of the company’s investment in ProShares UltraPro Short NASDAQ decreased from $17,000 to $3,000 decreasing 82.4% quarter to quarter. Jane Street Group, LLC reduced its ownership by selling 3,900 shares a decrease of 26.0% as of 06/30/2017. Jane Street Group, LLC now controls 11,100 shares worth $149,000. The value of the position overall is down by 40.6%.